Philips launches new virtual care management services

Health technology company Philips has launched a new virtual care management program to help health systems, providers, payers and employer groups connect with patients. 

The program targets chronic conditions, with condition-specific protocols for diabetes, hypertension, heart disease, chronic kidney disease, chronic obstructive pulmonary disease (COPD), plus gestational programs for diabetes and hypertension. According to Philips, 90% of healthcare expenditures in the United States go toward chronic care management, meaning there is a huge opportunity to lower costs and improve care.

Philips Virtual Care Management’s protocols connect to devices and engagement tools on a secure, cloud-based network with real-time data. Patients are monitored and offered personalized health coaching by licensed clinical professionals.

“Virtual care is paving the way to meaningfully reduce the cost of care through fewer hospitalizations and emergency department visits,” Nick Wilson, general manager, ambulatory virtual care at Philips, said in a statement. “Care providers and health systems today are often short on time and resources, accelerating the need to find new ways to gain visibility into patients’ health amid an overwhelming variety of options. For patients, the opportunity to understand and take proactive control of their health can potentially lead to improved outcomes.”

According to Philips, the program is already having success. Recent studies have shown patients saw a 38% average reduction in emergency department visits and an average HbA1c, or blood glucose, reduction of 3.06%. Study results also suggest potential savings of $3,086 in annual claims per patient or member, and fewer 30- and 90-day hospitalizations compared to usual care.

Currently available in the U.S., the program is customizable for providers, payers and employer groups who want to shape and scale it to their needs. 

The program comes after virtual care services have risen in popularity throughout the COVID-19 pandemic. When in-person services were temporarily halted at the start of the pandemic, virtual care exploded, but it has continued to remain an important part of healthcare services three years later, with more providers offering new services. 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.